Practice implications of the atrial fibrillation guidelines

American Journal of Cardiology

Volumn 111, Issue 11, 2013, Pages 1660-1670

  Curtis, Anne B ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APIXABAN; CLOPIDOGREL; DABIGATRAN; DABIGATRAN ETEXILATE; DRONEDARONE; PLACEBO; RIVAROXABAN; WARFARIN;

ABLATION THERAPY; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CLINICAL EVALUATION; DISEASE CONTROL; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; RISK REDUCTION; THROMBOSIS PREVENTION;

ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOLOGY; HUMANS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL;

EID: 84877830340     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.01.338     Document Type: Review

References (51)

1. K.A. Eagle, D.S. Cannom, and D.A. Garcia Management of atrial fibrillation: translating clinical trial data into clinical practice Am J Med 124 2011 4 14
2. G.V. Naccarelli, H. Varker, J. Lin, and K.L. Schulman Increasing prevalence of atrial fibrillation and flutter in the United States Am J Cardiol 104 2009 1534 1539
3. I. Savelieva, N. Kakouros, A. Kourliouros, and A.J. Camm Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention Europace 13 2011 308 328
4. L.S. Wann, A.B. Curtis, K.A. Ellenbogen, N.A. Estes III, M.D. Ezekowitz, W.M. Jackman, C.T. January, J.E. Lowe, R.L. Page, D.J. Slotwiner, W.G. Stevenson, and C.M. Tracy 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines J Am Coll Cardiol 57 2011 1330 1337
5. L.B. Mitchell Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery Can J Cardiol 27 2011 91 97
6. J.A. Cairns, S. Connolly, S. McMurtry, M. Stephenson, and M. Talajic Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter Can J Cardiol 27 2011 74 90
7. P. Page Canadian Cardiovascular Society atrial fibrillation guidelines 2010: surgical therapy Can J Cardiol 27 2011 67 73
8. A. Verma, L. Macle, J. Cox, and A.C. Skanes Canadian Cardiovascular Society atrial fibrillation guidelines 2010: catheter ablation for atrial fibrillation/atrial flutter Can J Cardiol 27 2011 60 66
9. A.M. Gillis, A. Verma, M. Talajic, S. Nattel, and P. Dorian Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management Can J Cardiol 27 2011 47 59
10. I.G. Stiell, and L. Macle Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department Can J Cardiol 27 2011 38 46
11. J.S. Healey, R. Parkash, T. Pollak, T. Tsang, and P. Dorian Canadian Cardiovascular Society atrial fibrillation guidelines 2010: etiology and initial investigations Can J Cardiol 27 2011 31 37
12. A.M. Gillis, and A.C. Skanes Canadian Cardiovascular Society atrial fibrillation guidelines 2010: implementing GRADE and achieving consensus Can J Cardiol 27 2011 27 30
13. A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, S. Ernst, I.C. Van Gelder, N. Al-Attar, G. Hindricks, B. Prendergast, H. Heidbuchel, O. Alfieri, A. Angelini, D. Atar, P. Colonna, R. De Caterina, J. De Sutter, A. Goette, B. Gorenek, M. Heldal, S.H. Hohloser, P. Kolh, J.Y. Le Heuzey, P. Ponikowski, and F.H. Rutten Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
14. L.S. Wann, A.B. Curtis, C.T. January, K.A. Ellenbogen, J.E. Lowe, N.A. Estes III, R.L. Page, M.D. Ezekowitz, D.J. Slotwiner, W.M. Jackman, W.G. Stevenson, C.M. Tracy, V. Fuster, L.E. Ryden, D.S. Cannom, J.Y. Le Heuzey, H.J. Crijns, S.B. Olsson, E.N. Prystowsky, J.L. Halperin, J.L. Tamargo, G.N. Kay, A.K. Jacobs, J.L. Anderson, N. Albert, J.S. Hochman, C.E. Buller, F.G. Kushner, M.A. Creager, E.M. Ohman, S.M. Ettinger, R.A. Guyton, L.G. Tarkington, and C.W. Yancy 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 57 2011 223 242
15. J.J. You, D.E. Singer, P.A. Howard, D.A. Lane, M.H. Eckman, M.C. Fang, E.M. Hylek, S. Schulman, A.S. Go, M. Hughes, F.A. Spencer, W.J. Manning, J.L. Halperin, and G.Y. Lip Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e531S e575S
16. S. Velu, and G.Y. Lip What is the role of the cardiologist in future management of stroke prevention in atrial fibrillation? Adv Ther 28 2011 1 12
17. G.Y. Lip Stroke in atrial fibrillation: epidemiology and thromboprophylaxis J Thromb Haemost 9 Suppl 1 2011 344 351
18. R. De Caterina, and E.M. Hylek Stroke prevention in atrial fibrillation: current status and near-future directions Am J Med 124 2011 793 799
19. I.M. Ogilvie, N. Newton, S.A. Welner, W. Cowell, and G.Y. Lip Underuse of oral anticoagulants in atrial fibrillation: a systematic review Am J Med 123 2010 638 645 e634
20. G.H. Guyatt, S.L. Norris, S. Schulman, J. Hirsh, M.H. Eckman, E.A. Akl, M. Crowther, P.O. Vandvik, J.W. Eikelboom, M.S. McDonagh, S.Z. Lewis, D.D. Gutterman, D.J. Cook, and H.J. Schunemann Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 53S 70S
21. G.H. Guyatt, E.A. Akl, M. Crowther, H.J. Schunemann, D.D. Gutterman, and S. Zelman Lewis Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 48S 52S
22. I.C. Van Gelder, D.J. Van Veldhuisen, H.J. Crijns, Y.S. Tuininga, J.G. Tijssen, A.M. Alings, H.A. Bosker, J.H. Cornel, O. Kamp, N.J. Veeger, M. Volbeda, M. Rienstra, A.V. Ranchor, E.M. TenVergert, and M.P. Van den Berg RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure: background, aims, and design of RACE II Am Heart J 152 2006 420 426
23. I.C. Van Gelder, H.F. Groenveld, H.J. Crijns, Y.S. Tuininga, J.G. Tijssen, A.M. Alings, H.L. Hillege, J.A. Bergsma-Kadijk, J.H. Cornel, O. Kamp, R. Tukkie, H.A. Bosker, D.J. Van Veldhuisen, and M.P. Van den Berg Lenient versus strict rate control in patients with atrial fibrillation N Engl J Med 362 2010 1363 1373
24. E.A. Martinez, A.E. Epstein, and E.B. Bass Pharmacologic control of ventricular rate: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery Chest 128 2005 56S 60S
25. D. Roy, M. Talajic, S. Nattel, D.G. Wyse, P. Dorian, K.L. Lee, M.G. Bourassa, J.M. Arnold, A.E. Buxton, A.J. Camm, S.J. Connolly, M. Dubuc, A. Ducharme, P.G. Guerra, S.H. Hohnloser, J. Lambert, J.Y. Le Heuzey, G. O'Hara, O.D. Pedersen, J.L. Rouleau, B.N. Singh, L.W. Stevenson, W.G. Stevenson, B. Thibault, and A.L. Waldo Rhythm control versus rate control for atrial fibrillation and heart failure N Engl J Med 358 2008 2667 2677
26. V. Fuster, L.E. Ryden, D.S. Cannom, H.J. Crijns, A.B. Curtis, K.A. Ellenbogen, J.L. Halperin, G.N. Kay, J.Y. Le Huezey, J.E. Lowe, S.B. Olsson, E.N. Prystowsky, J.L. Tamargo, and L.S. Wann 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society J Am Coll Cardiol 57 2011 e101 e198
27. D.G. Sherman, S.G. Kim, B.S. Boop, S.D. Corley, J.P. Dimarco, R.G. Hart, L.J. Haywood, K. Hoyte, E.S. Kaufman, M.H. Kim, E. Nasco, and A.L. Waldo Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study Arch Intern Med 165 2005 1185 1191
28. S. Connolly, J. Pogue, R. Hart, M. Pfeffer, S. Hohnloser, S. Chrolavicius, and S. Yusuf Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 2006 1903 1912
29. S.J. Connolly, J. Pogue, R.G. Hart, S.H. Hohnloser, M. Pfeffer, S. Chrolavicius, and S. Yusuf Effect of clopidogrel added to aspirin in patients with atrial fibrillation N Engl J Med 360 2009 2066 2078
30. A.J. Camm, G.Y. Lip, R. De Caterina, I. Savelieva, D. Atar, S.H. Hohnloser, G. Hindricks, P. Kirchhof, J.J. Bax, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, M. Tendera, A. Torbicki, A. Vahanian, S. Windecker, P. Vardas, N. Al-Attar, O. Alfieri, A. Angelini, C. Blomstrom-Lundqvist, P. Colonna, J. De Sutter, S. Ernst, A. Goette, B. Gorenek, R. Hatala, H. Heidbuchel, M. Heldal, S.D. Kristensen, J.Y. Le Heuzey, H. Mavrakis, L. Mont, P.P. Filardi, P. Ponikowski, B. Prendergast, F.H. Rutten, U. Schotten, I.C. Van Gelder, and F.W. Verheugt 2012 Focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation: developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 2012 2719 2747
31. A.M. Gillis, and A.C. Skanes Comparing the 2010 North American and European atrial fibrillation guidelines Can J Cardiol 27 2011 7 13
32. K. Wasmer, and L. Eckardt Management of atrial fibrillation around the world: a comparison of current ACCF/AHA/HRS, CCS, and ESC guidelines Europace 13 2011 1368 1374
33. D.R. Holmes Jr., D.J. Kereiakes, S. Garg, P.W. Serruys, G.J. Dehmer, S.G. Ellis, D.O. Williams, T. Kimura, and D.J. Moliterno Stent thrombosis J Am Coll Cardiol 56 2010 1357 1365
34. D.R. Holmes Jr., D.J. Kereiakes, N.S. Kleiman, D.J. Moliterno, G. Patti, and C.L. Grines Combining antiplatelet and anticoagulant therapies J Am Coll Cardiol 54 2009 95 109
35. B.N. Singh, S.J. Connolly, H.J. Crijns, D. Roy, P.R. Kowey, A. Capucci, D. Radzik, E.M. Aliot, and S.H. Hohnloser Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter N Engl J Med 357 2007 987 999
36. L. Køber, C. Torp-Pedersen, J.J. McMurray, O. Gøtzsche, S. Lévy, H. Crijns, J. Amlie, and J. Carlsen Increased mortality after dronedarone therapy for severe heart failure N Engl J Med 358 2008 2678 2687
37. S.J. Connolly, H.J. Crijns, C. Torp-Pedersen, M. van Eickels, C. Gaudin, R.L. Page, and S.H. Hohnloser Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter Circulation 120 2009 1174 1180
38. S.H. Hohnloser, H.J. Crijns, M. van Eickels, C. Gaudin, R.L. Page, C. Torp-Pedersen, and S.J. Connolly Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 2009 668 678
39. P. Touboul, J. Brugada, A. Capucci, H.J. Crijns, N. Edvardsson, and S.H. Hohnloser Dronedarone for prevention of atrial fibrillation: a dose-ranging study Eur Heart J 24 2003 1481 1487
40. J.Y. Le Heuzey, G.M. De Ferrari, D. Radzik, M. Santini, J. Zhu, and J.M. Davy A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study J Cardiovasc Electrophysiol 21 2010 597 605
41. FDA Drug Safety Communication: Multaq (dronedarone) and increased risk of death and serious cardiovascular adverse events. U.S. Food and Drug Administration. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm264059. htm#data. Accessed on December 9, 2011.
42. S.J. Connolly, A.J. Camm, J.L. Halperin, C. Joyner, M. Alings, J. Amerena, D. Atar, A. Avezum, P. Blomstrom, M. Borggrefe, A. Budaj, S.A. Chen, C.K. Ching, P. Commerford, A. Dans, J.M. Davy, E. Delacretaz, G. Di Pasquale, R. Diaz, P. Dorian, G. Flaker, S. Golitsyn, A. Gonzalez-Hermosillo, C.B. Granger, H. Heidbuchel, J. Kautzner, J.S. Kim, F. Lanas, B.S. Lewis, J.L. Merino, C. Morillo, J. Murin, C. Narasimhan, E. Paolasso, A. Parkhomenko, N.S. Peters, K.H. Sim, M.K. Stiles, S. Tanomsup, L. Toivonen, J. Tomcsanyi, C. Torp-Pedersen, H.F. Tse, P. Vardas, D. Vinereanu, D. Xavier, J. Zhu, J.R. Zhu, L. Baret-Cormel, E. Weinling, C. Staiger, S. Yusuf, S. Chrolavicius, R. Afzal, and S.H. Hohnloser Dronedarone in high-risk permanent atrial fibrillation N Engl J Med 365 2011 2268 2276
43. J.M. Davy, M. Herold, C. Hoglund, A. Timmermans, A. Alings, D. Radzik, and L. Van Kempen Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study Am Heart J 156 2008 527.e1 527.e9
44. R.L. Page, S.J. Connolly, H.J. Crijns, M. van Eickels, C. Gaudin, C. Torp-Pedersen, and S.H. Hohnloser Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial) Am J Cardiol 107 2011 1019 1022
45. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, J. Eikelboom, J. Oldgren, A. Parekh, J. Pogue, P.A. Reilly, E. Themeles, J. Varrone, S. Wang, M. Alings, D. Xavier, J. Zhu, R. Diaz, B.S. Lewis, H. Darius, H.C. Diener, C.D. Joyner, and L. Wallentin Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
46. Xarelto®. Approved for Stroke Prevention in Atrial Fibrillation by Health Canada, January 17, 2012: press release, Bayer, Inc. Available at: http://www.bayer.ca/?q=en/node/50. Accessed on April 27, 2012.
47. A.C. Skanes, J.S. Healey, J.A. Cairns, P. Dorian, A.M. Gillis, M.S. McMurtry, L.B. Mitchell, A. Verma, and S. Nattel Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control Can J Cardiol 28 2012 125 136
48. M.R. Patel, K.W. Mahaffey, J. Garg, G. Pan, D.E. Singer, W. Hacke, G. Breithardt, J.L. Halperin, G.J. Hankey, J.P. Piccini, R.C. Becker, C.C. Nessel, J.F. Paolini, S.D. Berkowitz, K.A.A. Fox, and R.M. Califf Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
49. S.J. Connolly, J. Eikelboom, C. Joyner, H.C. Diener, R. Hart, S. Golitsyn, G. Flaker, A. Avezum, S.H. Hohnloser, R. Diaz, M. Talajic, J. Zhu, P. Pais, A. Budaj, A. Parkhomenko, P. Jansky, P. Commerford, R.S. Tan, K.H. Sim, B.S. Lewis, W. Van Mieghem, G.Y. Lip, J.H. Kim, F. Lanas-Zanetti, A. Gonzalez-Hermosillo, A.L. Dans, M. Munawar, M. O'Donnell, J. Lawrence, G. Lewis, R. Afzal, and S. Yusuf Apixaban in patients with atrial fibrillation N Engl J Med 364 2011 806 817
50. C.B. Granger, J.H. Alexander, J.J.V. McMurray, R.D. Lopes, E.M. Hylek, M. Hanna, H.R. Al-Khalidi, J. Ansell, D. Atar, A. Avezum, M.C. Bahit, R. Diaz, J.D. Easton, J.A. Ezekowitz, G. Flaker, D. Garcia, M. Geraldes, B.J. Gersh, S. Golitsyn, S. Goto, A.G. Hermosillo, S.H. Hohnloser, J. Horowitz, P. Mohan, P. Jansky, B.S. Lewis, J.L. Lopez-Sendon, P. Pais, A. Parkhomenko, F.W.A. Verheugt, J. Zhu, and L. Wallentin Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
51. S. MacLean, S. Mulla, E.A. Akl, M. Jankowski, P.O. Vandvik, S. Ebrahim, S. McLeod, N. Bhatnagar, and G.H. Guyatt Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e1S 23S